Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Belinostat

Catalog No. T8517Cas No. 866323-14-0
Alias PXD-101, PXD101, PX105684

Belinostat (PXD101) is an inhibitor of hydroxamic acid-type histone deacetylase (HDAC, IC50 of 27 nM in HeLa cell extracts),and with antineoplastic activity.

Belinostat

Belinostat

Purity: 100%
Catalog No. T8517Alias PXD-101, PXD101, PX105684Cas No. 866323-14-0
Belinostat (PXD101) is an inhibitor of hydroxamic acid-type histone deacetylase (HDAC, IC50 of 27 nM in HeLa cell extracts),and with antineoplastic activity.
Pack SizePriceAvailabilityQuantity
5 mg$40In Stock
10 mg$63In Stock
25 mg$98In Stock
50 mg$147In Stock
100 mg$217In Stock
200 mg$323In Stock
500 mg$546In Stock
1 mL x 10 mM (in DMSO)$57In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Belinostat"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Belinostat (PXD101) is an inhibitor of hydroxamic acid-type histone deacetylase (HDAC, IC50 of 27 nM in HeLa cell extracts),and with antineoplastic activity.
Targets&IC50
HDAC6:82 nM , HDAC:27 nM (Hela cell)
In vitro
Belinostat is a novel hydroxamate-type inhibitor of histone deacetylase activity that inhibits histone deacetylase activity in HeLa cell extracts with an IC(50) of 27 nM and induces a concentration-dependent (0.2-5 micro M) increase in acetylation of histone H4 in tumor cell lines.Belinostat is cytotoxic in vitro in a number of tumor cell lines with IC(50)s in the range 0.2-3.4 micro M as determined by a clonogenic assay and induces apoptosis.
In vivo
Treatment of nude mice bearing human ovarian and colon tumor xenografts with PXD101 (10-40 mg/kg/day i.p.) for 7 days results in a significant, dose-dependent growth delay without obvious signs of toxicity. Growth delay is also observed in xenografts of cisplatin-resistant ovarian tumor cells. A significant increase in acetylation of H4 is detected in blood and tumor tissues 3 hours after treatment. These findings suggest that PXD101 has potential as a novel antitumor agent.
AliasPXD-101, PXD101, PX105684
Chemical Properties
Molecular Weight318.35
FormulaC15H14N2O4S
Cas No.866323-14-0
Storage & Solubility Information
Storagekeep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 135 mg/mL (424.068 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1412 mL15.7060 mL31.4120 mL157.0598 mL
5 mM0.6282 mL3.1412 mL6.2824 mL31.4120 mL
10 mM0.3141 mL1.5706 mL3.1412 mL15.7060 mL
20 mM0.1571 mL0.7853 mL1.5706 mL7.8530 mL
50 mM0.0628 mL0.3141 mL0.6282 mL3.1412 mL
100 mM0.0314 mL0.1571 mL0.3141 mL1.5706 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Belinostat | purchase Belinostat | Belinostat cost | order Belinostat | Belinostat chemical structure | Belinostat in vivo | Belinostat in vitro | Belinostat formula | Belinostat molecular weight